Cumberland Pharmaceuticals CPIX Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $11.01M-3.8% | $11.44M-24.7% | $15.2M-5.5% | $16.09M+6.5% | $15.11M-15.9% | ||
| $14.26M-15.8% | $16.94M+62.5% | $10.43M+1.1% | $10.32M-1.6% | $10.49M-10.4% | ||
| $9.88M+6.7% | $9.25M+0.8% | $9.18M-3.6% | $9.53M-4.2% | $9.94M-9.7% | ||
| $10.06M+2.3% | $9.83M+0.9% | $9.75M-6.1% | $10.38M-4.2% | $10.83M-9.6% | ||
| $5.27M-6.7% | $5.65M+143% | $2.32M+2.7% | $2.26M-24.9% | $3.01M+3.9% | ||
| $2.07M-15.5% | $2.45M+77.5% | $1.38M-12.7% | $1.58M-27.7% | $2.18M-21.7% | ||
| $32.79M-11.5% | $37.06M+23.8% | $29.94M-4.1% | $31.21M-2.1% | $31.88M-12.6% | ||
| $237.38K-10.3% | $264.72K-9.8% | $293.38K-1.5% | $297.79K-0.3% | $298.74K+7.7% | ||
| 9.4%0.0% | 9.4%0.0% | 9.4%0.0% | 9.4%0.0% | 9.4%-617,692,291% | ||
| $914K0.0% | $914K0.0% | $914K0.0% | $914K0.0% | $914K0.0% | ||
| $12.79M-8.8% | $14.03M-6.5% | $15.01M-6.1% | $15.99M-5.9% | $16.99M-5.5% | ||
| $100K-96.6% | $2.97M+2,873% | $100K-50.0% | $200K0.0% | $200K-92.8% | ||
| $3.84M-3.7% | $3.99M— | —— | —— | —— | ||
| $71M-7.6% | $76.82M+16.6% | $65.9M-3.0% | $67.91M-2.9% | $69.94M-7.5% | ||
| $16.54M-10.9% | $18.57M+34.2% | $13.83M+2.9% | $13.45M-3.5% | $13.93M+0.1% | ||
| $12.98M+2.7% | $12.64M+25.4% | $10.08M-0.6% | $10.14M-9.6% | $11.22M-8.4% | ||
| —— | $0— | —— | —— | —— | ||
| $485.16K+3.7% | $467.77K+16.5% | $401.45K+4.0% | $386.08K+4.0% | $371.09K+4.1% | ||
| $34.49M-6.1% | $36.74M+51.2% | $24.31M+1.4% | $23.97M-6.1% | $25.52M-19.3% | ||
| $4.34M-2.9% | $4.47M-2.7% | $4.6M-2.5% | $4.71M-2.4% | $4.83M-2.2% | ||
| $4.83M-2.2% | $4.94M-1.2% | $5M-2.0% | $5.1M-1.9% | $5.2M-1.8% | ||
| $5.62M-3.5% | $5.82M-2.2% | $5.95M-5.6% | $6.3M+4.9% | $6.01M-4.7% | ||
| $49.69M-4.9% | $52.28M+30.4% | $40.1M-0.3% | $40.23M-3.3% | $41.6M-21.6% | ||
| $51.73M+0.1% | $51.68M+0.3% | $51.51M+0.1% | $51.44M+0.1% | $51.37M+9.7% | ||
| -$30.09M-12.3% | -$26.8M-5.6% | -$25.39M-8.3% | -$23.45M-3.3% | -$22.71M+5.2% | ||
| -$333.51K+0.8% | -$336.1K-5.3% | -$319.15K-2.7% | -$310.87K+1.7% | -$316.4K-2.9% | ||
| $21.64M-13.0% | $24.88M-4.7% | $26.12M-6.7% | $27.99M-2.3% | $28.66M+25.4% | ||
| $71M-7.6% | $76.82M+16.6% | $65.9M-3.0% | $67.91M-2.9% | $69.94M-7.5% | ||
| $5.27M-6.7% | $5.65M+143% | $2.32M+2.7% | $2.26M-24.9% | $3.01M+3.9% | ||
| $10.06M+2.3% | $9.83M+0.9% | $9.75M-6.1% | $10.38M-4.2% | $10.83M-9.6% | ||
| $100K— | —— | $100K-50.0% | $200K0.0% | $200K— | ||
| $2.93M-1.6% | $2.97M-0.4% | $2.99M+4.8% | $2.85M+3.9% | $2.74M-1.5% | ||
| $100K-98.8% | $8.34M+8,244% | $100K-50.0% | $200K0.0% | $200K-96.8% | ||
| $44.1M— | —— | $44.1M0.0% | $44.1M0.0% | $44.1M— | ||
| $12.79M-8.8% | $14.03M-6.5% | $15.01M-6.1% | $15.99M-5.9% | $16.99M-5.5% | ||
| $3.84M-3.7% | $3.99M— | —— | —— | —— | ||
| $7.62M-8.7% | $8.34M+10.2% | $7.57M+6.2% | $7.13M-0.7% | $7.18M+16.2% | ||
| $2.93M-1.6% | $2.97M-0.4% | $2.99M+4.8% | $2.85M+3.9% | $2.74M-1.5% | ||
| $7.62M-8.7% | $8.34M+10.2% | $7.57M+6.2% | $7.13M-0.7% | $7.18M+16.2% | ||
| $2.93M-1.6% | $2.97M-0.4% | $2.99M+4.8% | $2.85M+3.9% | $2.74M-1.5% | ||
| $12.98M+2.7% | $12.64M+25.4% | $10.08M-0.6% | $10.14M-9.6% | $11.22M-8.4% | ||
| $684.56K— | —— | $173.98K-56.0% | $395.66K-35.8% | $616.61K— | ||
| $740.79K— | —— | $934.18K0.0% | $934.18K0.0% | $934.18K— | ||
| $667.05K— | —— | $650.77K0.0% | $650.77K0.0% | $650.77K— | ||
| $740.79K— | —— | $934.18K0.0% | $934.18K0.0% | $934.18K— | ||
| $650.77K— | —— | $740.79K0.0% | $740.79K0.0% | $740.79K— | ||
| $667.05K— | —— | $650.77K0.0% | $650.77K0.0% | $650.77K— | ||
| $934.18K— | —— | $909.91K0.0% | $909.91K0.0% | $909.91K— | ||
| $5.24M0.0% | $5.24M— | $0— | $0— | $0-100% | ||
| $7.21M— | —— | $7.61M-2.8% | $7.83M-2.7% | $8.05M— | ||
| $2.38M— | —— | $2.61M-4.3% | $2.73M-4.2% | $2.85M— | ||
| $650.77K— | —— | $740.79K0.0% | $740.79K0.0% | $740.79K— | ||
| $667.05K— | —— | $650.77K0.0% | $650.77K0.0% | $650.77K— | ||
| $4.83M-2.2% | $4.94M-1.2% | $5M-2.0% | $5.1M-1.9% | $5.2M-50.0% | ||
| $0.00— | $0.00— | $0.00— | $0.00— | —— | ||
| 15M+0.2% | 15M0.0% | 15M0.0% | 15M0.0% | 15M+7.2% | ||
| $2.1M— | —— | $2.2M0.0% | $2.2M0.0% | $2.2M— | ||
| $2.1M— | —— | $2.2M0.0% | $2.2M0.0% | $2.2M— | ||
| $0— | $0— | $0— | $0— | —— | ||
| $100M0.0% | $100M0.0% | $100M0.0% | $100M0.0% | $100M0.0% | ||
| $14.98M+0.2% | $14.96M0.0% | $14.96M0.0% | $14.96M0.0% | $14.96M+7.2% | ||
| $14.98M+0.2% | $14.96M0.0% | $14.96M0.0% | $14.96M0.0% | $14.96M+7.2% | ||
| $4.49M-11.6% | $5.07M— | —— | —— | —— | ||
| $7.21M— | —— | $7.61M-2.8% | $7.83M-2.7% | $8.05M— | ||
| $3.53M— | —— | $4.2M0.0% | $4.2M0.0% | $4.2M— | ||
| $2.38M— | —— | $2.61M-4.3% | $2.73M-4.2% | $2.85M— | ||
| —— | —— | —— | —— | —— | ||
| $5.24M0.0% | $5.24M0.0% | $5.24M0.0% | $5.24M0.0% | $5.24M-48.5% | ||
| -$333.51K+0.8% | -$336.1K-5.3% | -$319.15K-2.7% | -$310.87K+1.7% | -$316.4K-2.9% | ||
| $0.09-0.1% | $0.09-0.1% | $0.090.0% | $0.090.0% | $0.09-0.1% | ||
| $44.1M— | —— | $44.1M0.0% | $44.1M0.0% | $44.1M— | ||
| $2.1M— | —— | $2.2M0.0% | $2.2M0.0% | $2.2M— | ||
| $684.56K— | —— | $173.98K-56.0% | $395.66K-35.8% | $616.61K— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Cumberland Pharmaceuticals's total assets?
- Cumberland Pharmaceuticals (CPIX) holds $71.0M in total assets, up 1.5% year over year.
- How much debt does Cumberland Pharmaceuticals have?
- Cumberland Pharmaceuticals carries $4.8M in total debt against $21.6M of shareholders' equity, a debt-to-equity ratio of 0.22.
- How much cash does Cumberland Pharmaceuticals have?
- Cumberland Pharmaceuticals holds $11.0M in cash and equivalents.
- Can Cumberland Pharmaceuticals cover its short-term obligations?
- Its current ratio is 0.95 — current liabilities exceed current assets.
- Where does Cumberland Pharmaceuticals's balance sheet data come from?
- Every line is extracted from Cumberland Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
